{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:36:21Z","timestamp":1790361381214,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:00:00Z","timestamp":1589241600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedical Journal"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.bj.2020.05.001","type":"journal-article","created":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T12:40:03Z","timestamp":1589546403000},"page":"355-362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":193,"title":["Artificial intelligence approach fighting COVID-19 with repurposing drugs"],"prefix":"10.1016","volume":"43","author":[{"given":"Yi-Yu","family":"Ke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Ting","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng-Kuang","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Zheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-En","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szu-Huei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Chen","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsu-An","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiow-Ju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeng-Shin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hsing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tung-Jung","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiunn-Horng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huey-Kang","family":"Sytwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiung-Tong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bj.2020.05.001_bib1","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ijid.2020.01.009","article-title":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China","volume":"91","author":"Hui","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.bj.2020.05.001_bib2","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2460\/ajvr.1976.37.12.1449","article-title":"Serologic studies of naturally occurring feline infectious peritonitis","volume":"37","author":"Pedersen","year":"1976","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.bj.2020.05.001_bib3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jfms.2003.11.001","article-title":"Human severe acute respiratory syndrome (SARS) and feline coronaviruses","volume":"6","author":"Paltrinieri","year":"2004","journal-title":"J Feline Med Surg"},{"key":"10.1016\/j.bj.2020.05.001_bib4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/1098612X19825701","article-title":"Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis","volume":"21","author":"Pedersen","year":"2019","journal-title":"J Feline Med Surg"},{"key":"10.1016\/j.bj.2020.05.001_bib5","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1177\/1098612X17729626","article-title":"Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis","volume":"20","author":"Pedersen","year":"2018","journal-title":"J Feline Med Surg"},{"key":"10.1016\/j.bj.2020.05.001_bib6","doi-asserted-by":"crossref","first-page":"eaal3653","DOI":"10.1126\/scitranslmed.aal3653","article-title":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses","volume":"28","author":"Sheahan","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.bj.2020.05.001_bib7","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1021\/ci100050t","article-title":"Extended-connectivity fingerprints","volume":"50","author":"Rogers","year":"2010","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bj.2020.05.001_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1021\/ci00053a005","article-title":"Atomic physicochemical parameters for three-dimensional-structure-directed quantitative structure-activity relationships. 2. Modeling dispersive and hydrophobic interactions","volume":"27","author":"Ghose","year":"1987","journal-title":"J Chem Inf Comput Sci"},{"key":"10.1016\/j.bj.2020.05.001_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1021\/ci500747n","article-title":"Deep neural nets as a method for quantitative structure-activity relationships","volume":"55","author":"Ma","year":"2015","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bj.2020.05.001_bib10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1741-7015-10-104","article-title":"New treatments for influenza","volume":"10","author":"Barik","year":"2012","journal-title":"BMC Med"},{"key":"10.1016\/j.bj.2020.05.001_bib11","first-page":"329","article-title":"Pharmacokinetics of anti-SARS-CoV agent niclosamide and its analogs in rats","volume":"14","author":"Chang","year":"2006","journal-title":"J Food Drug Anal"},{"key":"10.1016\/j.bj.2020.05.001_bib12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1470-2045(08)70334-6","article-title":"Anti-HIV drugs for cancer therapeutics: back to the future?","volume":"10","author":"Chow","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bj.2020.05.001_bib13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.joim.2020.02.004","article-title":"Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2)","volume":"18","author":"Ling","year":"2020","journal-title":"J Integr Med"},{"key":"10.1016\/j.bj.2020.05.001_bib14","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.26633\/RPSP.2020.40","article-title":"Clinical trials on drug repositioning for COVID-19 treatment","volume":"44","author":"Rosa","year":"2020","journal-title":"Rev Panam Salud Publica"},{"key":"10.1016\/j.bj.2020.05.001_bib15","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.chembiol.2004.08.011","article-title":"High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase","volume":"11","author":"Blanchard","year":"2004","journal-title":"Chem Biol"},{"key":"10.1016\/j.bj.2020.05.001_bib16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/ecam\/neh081","article-title":"Inhibition of SARS-CoV 3C-like protease activity by theaflavin-3,3'-digallate (TF3)","volume":"2","author":"Chen","year":"2005","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.bj.2020.05.001_bib17","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1177\/1087057106293295","article-title":"Discovering severe acute respiratory syndrome coronavirus 3CL protease inhibitors: virtual screening, surface plasmon resonance, and fluorescence resonance energy transfer assays","volume":"11","author":"Chen","year":"2006","journal-title":"J Biomol Screen"},{"key":"10.1016\/j.bj.2020.05.001_bib18","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1016\/j.bmcl.2005.04.027","article-title":"Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors","volume":"15","author":"Chen","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bj.2020.05.001_bib19","doi-asserted-by":"crossref","first-page":"5684","DOI":"10.1016\/j.bmcl.2008.08.082","article-title":"Design, synthesis and antiviral efficacy of a series of potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitors","volume":"18","author":"Ghosh","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bj.2020.05.001_bib20","doi-asserted-by":"crossref","first-page":"5876","DOI":"10.1016\/j.bmcl.2007.08.031","article-title":"Structure-based design, synthesis, and biological evaluation of peptidomimetic SARS-CoV 3CLpro inhibitors","volume":"17","author":"Ghosh","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bj.2020.05.001_bib21","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/jm301580n","volume":"56","author":"Jacobs","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bj.2020.05.001_bib22","doi-asserted-by":"crossref","first-page":"6113","DOI":"10.1021\/jm0494873","article-title":"Synthesis and evaluation of keto-glutamine analogues as potent inhibitors of severe acute respiratory syndrome 3CLpro","volume":"47","author":"Jain","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.bj.2020.05.001_bib23","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.chembiol.2004.07.013","article-title":"Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics","volume":"11","author":"Kao","year":"2004","journal-title":"Chem Biol"},{"key":"10.1016\/j.bj.2020.05.001_bib24","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.febslet.2008.12.059","article-title":"Individual and common inhibitors of coronavirus and picornavirus main proteases","volume":"583","author":"Kuo","year":"2009","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bj.2020.05.001_bib25","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.1021\/jm060207o","article-title":"Structure-based drug design and structural biology study of novel nonpeptide inhibitors of severe acute respiratory syndrome coronavirus main protease","volume":"49","author":"Lu","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.bj.2020.05.001_bib26","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1016\/j.bmc.2008.01.011","article-title":"Structure-based virtual screening against SARS-3CL(pro) to identify novel non-peptidic hits","volume":"16","author":"Mukherjee","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bj.2020.05.001_bib27","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ejmech.2013.05.005","article-title":"Design, synthesis, and biological evaluation of novel dipeptide-type SARS-CoV 3CL protease inhibitors: structure-activity relationship study","volume":"65","author":"Thanigaimalai","year":"2013","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bj.2020.05.001_bib28","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ejmech.2013.07.037","article-title":"Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: design, synthesis, biological evaluation, and docking studies","volume":"68","author":"Thanigaimalai","year":"2013","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bj.2020.05.001_bib29","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1021\/jm050852f","article-title":"Discovery of a novel family of SARS-CoV protease inhibitors by virtual screening and 3D-QSAR studies","volume":"49","author":"Tsai","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.bj.2020.05.001_bib30","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.1016\/j.bmcl.2013.08.112","article-title":"Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding","volume":"23","author":"Turlington","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bj.2020.05.001_bib31","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1021\/jm070295s","article-title":"Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus","volume":"50","author":"Wen","year":"2007","journal-title":"J Med Chem"},{"key":"10.1016\/j.bj.2020.05.001_bib32","doi-asserted-by":"crossref","first-page":"10012","DOI":"10.1073\/pnas.0403596101","article-title":"Small molecules targeting severe acute respiratory syndrome human coronavirus","volume":"101","author":"Wu","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bj.2020.05.001_bib33","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1248\/cpb.56.1400","article-title":"Design and synthesis of cinanserin analogs as severe acute respiratory syndrome coronavirus 3CL protease inhibitors","volume":"56","author":"Yang","year":"2008","journal-title":"Chem Pharm Bull"},{"key":"10.1016\/j.bj.2020.05.001_bib34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bioorg.2008.01.001","article-title":"Aryl methylene ketones and fluorinated methylene ketones as reversible inhibitors for severe acute respiratory syndrome (SARS) 3C-like proteinase","volume":"36","author":"Zhang","year":"2008","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bj.2020.05.001_bib35","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1021\/jm061425k","article-title":"Design, synthesis, and evaluation of inhibitors for severe acute respiratory syndrome 3C-like protease based on phthalhydrazide ketones or heteroaromatic esters","volume":"50","author":"Zhang","year":"2007","journal-title":"J Med Chem"},{"key":"10.1016\/j.bj.2020.05.001_bib36","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s11262-012-0864-0","article-title":"Full genome analysis of a novel type II feline coronavirus NTU156","volume":"46","author":"Lin","year":"2013","journal-title":"Virus Gene"},{"key":"10.1016\/j.bj.2020.05.001_bib37","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Epidemiology"},{"key":"10.1016\/j.bj.2020.05.001_bib38","doi-asserted-by":"crossref","first-page":"6832","DOI":"10.1021\/jm0501782","article-title":"A new lead for nonpeptidic active-site-directed inhibitors of the severe acute respiratory syndrome coronavirus main protease discovered by a combination of screening and docking methods","volume":"48","author":"Kaeppler","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.bj.2020.05.001_bib39","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in\u00a0vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.bj.2020.05.001_bib40","doi-asserted-by":"crossref","first-page":"104786","DOI":"10.1016\/j.antiviral.2020.104786","article-title":"Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in\u00a0vitro","volume":"178","author":"Choy","year":"2020","journal-title":"Antivir Res"},{"key":"10.1016\/j.bj.2020.05.001_bib41","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11095-020-02799-8","article-title":"Tilorone: a broad-spectrum antiviral invented in the USA and commercialized in Russia and beyond","volume":"37","author":"Ekins","year":"2020","journal-title":"Pharmaceut Res"},{"key":"10.1016\/j.bj.2020.05.001_bib42","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3390\/v10120721","article-title":"Development of small-molecule MERS-CoV inhibitors","volume":"10","author":"Liang","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.bj.2020.05.001_bib43","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1080\/14728222.2018.1536748","article-title":"The emergence of dihydroorotate dehydrogenase (DHODH) as a therapeutic target in acute myeloid leukemia","volume":"22","author":"Sykes","year":"2018","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.bj.2020.05.001_bib44","first-page":"4648","article-title":"Phase-I clinical and pharmacokinetic trial of brequinar sodium (Dup 785 Nsc 368390)","volume":"49","author":"Arteaga","year":"1989","journal-title":"Canc Res"},{"key":"10.1016\/j.bj.2020.05.001_bib45","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF00273407","article-title":"Distribution of the novel anticancer drug candidate brequinar sodium (Dup-785, Nsc-368390) into Normal and tumor-tissues of nude-mice bearing human-colon carcinoma xenografts","volume":"22","author":"Shen","year":"1988","journal-title":"Canc Chemother Pharmacol"},{"key":"10.1016\/j.bj.2020.05.001_bib46","first-page":"281","article-title":"Tissue concentration, systemic distribution and toxicity of clofazimine-an autopsy study","volume":"47","author":"Jadhav","year":"2004","journal-title":"Indian J Pathol Microbiol"},{"key":"10.1016\/j.bj.2020.05.001_bib47","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1128\/AAC.00260-15","article-title":"Pharmacokinetics and pharmacodynamics of clofazimine in a mouse model of tuberculosis","volume":"59","author":"Swanson","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bj.2020.05.001_bib48","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2147\/DDDT.S125459","article-title":"Pharmacokinetics of conivaptan use in patients with severe hepatic impairment","volume":"11","author":"Marbury","year":"2017","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.bj.2020.05.001_bib49","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00280-010-1255-7","article-title":"Pharmacokinetic study of gemcitabine, given as prolonged infusion at fixed dose rate, in combination with cisplatin in patients with advanced non-small-cell lung cancer","volume":"65","author":"Caffo","year":"2010","journal-title":"Canc Chemother Pharmacol"},{"key":"10.1016\/j.bj.2020.05.001_bib50","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.kint.2016.11.029","article-title":"Capillary leak syndrome: etiologies, pathophysiology, and management","volume":"92","author":"Siddall","year":"2017","journal-title":"Kidney Int"}],"container-title":["Biomedical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417020300494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417020300494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:07:51Z","timestamp":1762420071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2319417020300494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S2319417020300494"],"URL":"https:\/\/doi.org\/10.1016\/j.bj.2020.05.001","relation":{},"ISSN":["2319-4170"],"issn-type":[{"value":"2319-4170","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artificial intelligence approach fighting COVID-19 with repurposing drugs","name":"articletitle","label":"Article Title"},{"value":"Biomedical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bj.2020.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Chang Gung University. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}